Wholesale of pharmaceutical and medical goods
BELLMAN & SYMFON NORGE AS
Revenue 2025
NOK 3.6m
Operating profit
NOK 98,000
Equity
NOK 2.4m
Incorporated
1985
Share capital
NOK 50,000
Key figures · 2025
Current ratio
2.44
Equity ratio
59.1%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 2.7% | |
| Net margin (%%) | 2.1% | |
| Return on assets (%%) | 2.4% | |
| Likviditet | ||
| Current ratio | 2.44 | |
| Working capital | 2.4m | |
| Soliditet | ||
| Equity ratio (%%) | 59.1% | |
| Debt-to-equity ratio | 0.69 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.